Pilot Projects Program

试点项目计划

• 批准号: 10630581
• 负责人: DAVID E STEC
• 金额: $ 38.75万
• 依托单位: UNIVERSITY OF MISSISSIPPI MED CTR
• 依托单位国家: 美国
• 财政年份: 2023
• 资助国家: 美国
• 起止时间: 2023-07-15 至 2028-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10630581
• 关键词: Affect; American Heart Association; Appointment; Area; Basic Science; Book Chapters; Cardiorenal syndrome; Cardiovascular Diseases; Categories; Centers of Research Excellence; Clinical Research; Clinical Sciences; Communities; Conflict of Interest; Data; Development; Discipline; Education; Eligibility Determination; Equity; Evaluation; Exposure to; Extramural Activities; Faculty; Financial Support; Funding; Goals; Grant; Grant Review; Health; Individual; International; Journals; Medical center; Mentors; Metabolic Diseases; Mississippi; Paper; Phase; Pilot Projects; Population Research; Program Research Project Grants; Publishing; Research; Research Infrastructure; Research Personnel; Research Project Grants; Research Proposals; Resources; Review Committee; Scientist; Series; Services; Study Section; Testing; United States; United States National Institutes of Health; Universities; base; career; ethnic diversity; experience; gender diversity; improved; innovation; meetings; member; mid-career faculty; multidisciplinary; next generation; novel; programs; satisfaction; success; translational potential

PILOT PROJECTS PROGRAM SUMMARY/ABSTRACT The Cardiorenal and Metabolic Diseases Research Center (CMDRC) at the University of Mississippi Medical Center (UMMC) developed a highly successful Pilot Projects Program (PPP) during Phases 1 and 2 of COBRE support. Over the past 9 years, the CMDRC PPP has provided funding, mentoring, core services, and enhanced research infrastructure for 24 pilot grant investigators. The success of this program is highlighted by ~$26.92 million dollars in extramural funding obtained by previous PPP awardees as well as 459 papers published in leading journals in the field, 15 book chapters and 286 presentations at international and national meetings. To amplify the research base developed in Phases 1 and 2, the Phase 3 PPP will continue to support innovative research in the areas of cardiorenal and metabolic diseases. The PPP has four specific aims to achieve these goals: 1) To enhance the PPP developed during Phases 1 and 2, with continued emphasis on soliciting and identifying a diverse group of promising investigators whose research focuses on cardiorenal and metabolic diseases for mentoring and funding to expand the critical mass of extramurally funded CMDRC investigators; 2) To provide rigorous ongoing evaluation of the progress of individual PPP awardees and the overall PPP to maximize the impact on the investigators mentored and funded through this program; 3) To facilitate formation of new collaborative, multidisciplinary teams of investigators whose complementary expertise catalyzes the development of translational projects that result in competitive, cutting- edge multi-PI proposals for extramural funding; 4) To increase the critical mass of investigators in cardiorenal and metabolic diseases research at UMMC and to provide mentoring and funding to increase their competiveness for conducting extramurally funded basic, clinical and population research. Thus, the PPP in Phase 3 will continue to provide mentoring as well as financial and developmental support for innovative cardiorenal and metabolic diseases projects to further increase the number and diversity of funded CMDRC researchers.

试点项目 总结/摘要 密西西比医科大学肾脏和代谢疾病研究中心（CMDRC） 在COBRE的第一和第二阶段，UMMC中心开发了一个非常成功的试点项目计划（PPP 支持.在过去的9年里，CMDRC PPP提供了资金，指导，核心服务， 为24名试点赠款调查员加强了研究基础设施。该计划的成功突出体现在 以前的PPP获奖者获得了约2692万美元的校外资金以及459篇论文 在该领域的主要期刊上发表，15本书的章节和286次国际和国家会议上的演讲 会议.为了扩大第一和第二阶段发展的研究基础，第三阶段公私营合作计划将继续 支持心肾和代谢疾病领域的创新研究。PPP有四个具体的 旨在实现这些目标：1）加强第1和第2阶段期间开发的PPP， 强调征求和确定一个有前途的研究人员，其研究重点是多样化的群体， 心肾和代谢疾病的指导和资金，以扩大临界质量的壁外 资助CMDRC调查员; 2）对个别PPP的进展进行严格的持续评估 获奖者和整个PPP，以最大限度地提高对调查人员的影响，并通过这一点得到指导和资助 3）促进形成新的合作，多学科的研究人员团队， 互补的专业知识促进了翻译项目的发展，从而产生竞争力，切割- 边缘多PI建议校外资助; 4）增加心肾研究者的临界质量 和代谢疾病的研究，并提供指导和资金，以增加他们的 开展由校外资助的基础、临床和人口研究的竞争力。因此， 第三阶段将继续提供指导以及财政和发展支持， 心肾和代谢疾病项目，以进一步增加资助的CMDRC的数量和多样性 研究人员